1-03-2023, 02:13

G1 Therapeutics to Participate in the Cowen 43rd Annual

RESEARCH TRIANGLE PARK, N.C., Feb. 28, 2023 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX), a
Globe Newswire1-03-2023, 02:13
22-02-2023, 22:10

G1 Therapeutics to Release Fourth Quarter and Full Year

RESEARCH TRIANGLE PARK, N.C., Feb. 22, 2023 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX), a
Globe Newswire22-02-2023, 22:10
13-02-2023, 18:03

G1 Therapeutics Announces Top Line Results from Pivotal

- PRESERVE 1 Achieved its Co-Primary Endpoints Showing Statistically Significant Reductions in Occurrence of Severe
Globe Newswire13-02-2023, 18:03
2-02-2023, 04:47

G1 Therapeutics Announces Inducement Grants Under Nasdaq

RESEARCH TRIANGLE PARK, N.C., Feb. 01, 2023 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX), a
Globe Newswire2-02-2023, 04:47